CSIMarket
 
Haemonetics Corporation  (HAE)
Other Ticker:  
 
 


Haemonetics Corporation announced memorable behavior, over the financial third quarter of 2023

HAE announced third quarter of 2023 operating surplus of $43.279 millions

Published 2023-03-24T17:22:51+00:00
Goran Soko / CSIMarket.com Contributer

Tomography_(CAT)_scan_pd the Medical Equipment & Supplies company had astonishing Dec 31 2022 report, where profit per share jumped by 42.22 % to $0.64 per share, followed by Revenue rise of 17.528 % to $305.30 millions, compared with the prior year period.

Eps remained unscathed from the prior reporting season from $0.64 per share, Revenues grew by 2.627 % from $297.49 millions.


Net income of $32.944 millions in the October to December 31 2022 period increased by 41.8 % from net earnings of $23.232 millions reported in the October to December 31 2022 period a year ago. Haemonetics Corporation also emphasized it's improving profit margins, where net margin rose to 10.79% in October to December 31 2022 period, and operating margin edged up to 14.18%.
Operating earnings, on the other hand, improved just 21.4% to $43.279 millions.

Haemonetics Corporation is expected to report next financial recent numbers on May 24, 2023.


Haemonetics Corporation Competitors, Market Share

Haemonetics Corporation Revenue advance Rates

    Recently Reported Results
Radiant Logistics Inc

Facing difficult business enviroment, with rather steep -16.423 %, Revenues decrease, the the company in the second quarter of 2023 earnings season

In the fiscal time-frame closing December 31 2022 RLGT disclosed soft top and bottom-line, where income per share dropped by -28.57 % and revenue by -16.423 % year on year. Revenue were to $278.12 millions relative to $332.77 millions eps at $0.10 in proportion to $0.14 in the comparable period a year before.

Radiant Logistics Inc Competitors, Market Share

Radiant Logistics Inc Income Statement, Balance sheets, Cash Flow Statement

housing-58496_960_720 Housing Starts


New housing units authorized by region

New housing units started by region

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Cytomx Therapeutics Inc

Focusing on the fiscal three months ending December 31 2022 the Major Pharmaceutical Preparations company lost money at $-0.42 per share, relative to the recent numbers of $-0.91 per share a year prior quarter, In the previous quarter the Cytomx Therapeutics Inc realized $-0.35 per share.

Cytomx Therapeutics Inc Suppliers

Cytomx Therapeutics Inc Suppliers

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Acer Therapeutics Inc

For the fiscal period ending December 31 2022 Acer Therapeutics Inc increased a shortfall per share of $-0.54 per share compare to $-0.30 a year ago and grew shortfall from $-0.31 per share from the preceding financial reporting period.

Revenues remained unchanged to $0.00 millions from $0.36 millions in the similar financial reporting period a year ago and sequentially Revenue Tumbled from $0.00 millions.

Acer Therapeutics Inc Competitors, Market Share

Acer Therapeutics Inc Suppliers

Pennsylvania Real Estate Investment Trust

Pennsylvania Real Estate Investment Trust reported that Revenues decreased slightly , in the fourth quarter of 2022

For the fourth quarter of 2022 earnings season PRET Deficit has swelled of $-7.81 per share compare to $-0.43 a year prior and earnings per share improved from $-14.52 per share from the prior reporting season.

Revenues decreased by -5.307 % to $80.65 millions from $85.17 millions in the similar reporting season a year prior and sequentially Revenues advanced by 10.767 % from $72.81 millions.

Pennsylvania Real Estate Investment Trust stock quotes, charts, profile

Pennsylvania Real Estate Investment Trust Revenue elevation Rates

Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Durable Goods Orders

Durable Goods orders rebounded in October

U.S. Durable Goods orders grew again after dipping in the last month, but orders excluding volatile transportation sector decreased. That category excludes defense and transportation and gives a better indication of longer-term trends in the private sector.

dollar-1175048_960_720 Gross Domestic Product

Gross Domestic Product grows 2.6 % in the third-quarter

U.S. economy grows to an annual rate of 2.6 %, as the U.S. trade balance improves.

factory_night_long_exposure_industry_power_industrial_energy_global-589754 Industrial production

U.S. production output continued to fell


Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Terns Pharmaceuticals Inc

For the fiscal span closing December 31 2022 TERN decreased a loss per share of $-0.23 per share compare to $-0.56 a year prior and Income per Share improved from $-0.44 per share from the preceding quarter.

Revenues remained unscathed to $0.00 millions from $1.00 millions in the corresponding quarter a year prior and sequentially Revenues advanced from $0.00 millions.

Terns Pharmaceuticals Inc Competitors, Market Share

Terns Pharmaceuticals Inc Revenue improvement Rates

Aerial_open_mine_by_Steve_Jurvetson__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Gold Royalty Corp

For the fourth quarter of 2022 earnings season GROY lost money of $-0.14 per share compare to $-0.14 a year prior and from $0.00 per share from the preceding financial reporting period.

Revenues remained unaffected by 0 % to $3.94 millions from $3.94 millions in the similar financial reporting period a year prior and sequentially Revenues advanced from $0.00 millions.

Gold Royalty Corp Competitors, Market Share

Gold Royalty Corp Suppliers

BuySell_pd.jpg P10 Inc

Concentrating on the most recent fiscal period P10 Inc bottom-line turned positive at $0.03 per share, relative to the earnings of $-3.47 per share a year ago reporting season, In the prior reporting season the Investment Services company realized $0.05 per share.

P10 Inc Customers

P10 Inc Revenue elevation Rates

LLPX_2235_User.Morven__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Freightcar America Inc

An Outstanding 52.021%, rise in Revenues at Freightcar America Inc in the second quarter of 2022

For the April to June 30 2022 time-frame Freightcar America Inc had turn a round to profits by presenting EPS of $0.58 per share compare to $-0.13 a year prior and EPS turned positive from $-1.11 per share from the preceding quarter.

Revenues inched up strongly by 52.021 % to $56.79 millions from $37.35 millions in the comparable quarter a year prior and sequentially Revenue Tumbled by -39.094 % from $93.24 millions.

Freightcar America Inc Customers

Freightcar America Inc improvement Rates, Profitability, PE

Shopping_Malll_Antwerpen_By_FaceMePLS_from_The_Hague_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Abercrombie And Fitch Co

The company reported a simple Revenues growth, in the fiscal period closing Jan 28 2023

Abercrombie And Fitch Co reported declining eps on increasing revenue in the fiscal period closing Jan 28 2023, where Revenue rose by 3.312 % to $1.20 billions in comparison to $1.16 billions on a year-over-year basis, while income per share dropped by -29.1 % to $0.78 per share, income per share was $1.10 in the fiscal period ending January 28 2023.

Abercrombie And Fitch Co Competitors, Market Share

Abercrombie And Fitch Co elevation Rates, Profitability, PE

Spectral Capital Corporation

In the most recent fiscal period company reached balanced books at $0.00 per share, opposite of $0.00 per share a year prior quarter, In the previous quarter Spectral Capital Corporation realized $0.00 per share.

Spectral Capital Corporation stock quotes, charts, profile

Spectral Capital Corporation Revenue improvement Rates



Other HAE's Earnings Reports

Haemonetics reported third quarter 2022 earnings

Haemonetics reported second quarter 2022 earnings

Haemonetics reported first quarter 2022 earnings

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NDSN's Profile

Stock Price

NDSN's Financials

Business Description

Fundamentals

Charts & Quotes

NDSN's News

Suppliers

NDSN's Competitors

Customers & Markets

Economic Indicators

NDSN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071